Patent Yard Sign in
Canadian application, no grantCanada

Sustained-release compositions

CA 2466633 A1 · Owner: Quadrant Drug Delivery Limited · Inventors: Blair, Julian; Martyn, Glen Patrick

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Microparticles comprise a therapeutic agent dispersed within a polymer matrix the matrix comprising a first polymer of hyaluronic acid and a second polymer of either a non-ionic polymer, a polymeric gum or a combination thereof. The microparticles may be formulated for nasal or pulmonary delivery.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 9, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 9, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 9, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 9, 2002
GrantedNo grant recorded
Term endedDecember 9, 2022
Patent numberCA 2466633 A1
Classification (IPC)A61K9/16 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedDec 9, 2002Term endedDec 9, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.